105 related articles for article (PubMed ID: 19368771)
1. Role of lipopolysaccharide in the induction of type I interferon-dependent cross-priming and IL-10 production in mice by meningococcal outer membrane vesicles.
Durand V; Mackenzie J; de Leon J; Mesa C; Quesniaux V; Montoya M; Le Bon A; Wong SY
Vaccine; 2009 Mar; 27(13):1912-22. PubMed ID: 19368771
[TBL] [Abstract][Full Text] [Related]
2. TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model.
Cyr SL; Angers I; Guillot L; Stoica-Popescu I; Lussier M; Qureshi S; Burt DS; Ward BJ
Vaccine; 2009 Jan; 27(3):421-30. PubMed ID: 19013492
[TBL] [Abstract][Full Text] [Related]
3. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production.
Abdollahi-Roodsaz S; Joosten LA; Helsen MM; Walgreen B; van Lent PL; van den Bersselaar LA; Koenders MI; van den Berg WB
Arthritis Rheum; 2008 Dec; 58(12):3753-64. PubMed ID: 19035506
[TBL] [Abstract][Full Text] [Related]
4. Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease.
Sobek V; Birkner N; Falk I; Würch A; Kirschning CJ; Wagner H; Wallich R; Lamers MC; Simon MM
Arthritis Res Ther; 2004; 6(5):R433-46. PubMed ID: 15380043
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide stimulation of dendritic cells induces interleukin-10 producing allergen-specific T cells in vitro but fails to prevent allergic airway disease.
Ahrens B; Freund T; Rha RD; Dittrich AM; Quarcoo D; Hutloff A; Hamelmann E
Exp Lung Res; 2009 May; 35(4):307-23. PubMed ID: 19415548
[TBL] [Abstract][Full Text] [Related]
6. Essential role of Toll-like receptors for dendritic cell and NK1.1(+) cell-dependent activation of type 1 immunity by Lactobacillus pentosus strain S-PT84.
Koizumi S; Wakita D; Sato T; Mitamura R; Izumo T; Shibata H; Kiso Y; Chamoto K; Togashi Y; Kitamura H; Nishimura T
Immunol Lett; 2008 Oct; 120(1-2):14-9. PubMed ID: 18620001
[TBL] [Abstract][Full Text] [Related]
7. Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells.
Zhang X; Deriaud E; Jiao X; Braun D; Leclerc C; Lo-Man R
J Exp Med; 2007 May; 204(5):1107-18. PubMed ID: 17485512
[TBL] [Abstract][Full Text] [Related]
8. The role of Toll-like receptors 2 and 4 on reactive oxygen species and nitric oxide production by macrophage cells stimulated with root canal pathogens.
Marcato LG; Ferlini AP; Bonfim RC; Ramos-Jorge ML; Ropert C; Afonso LF; Vieira LQ; Sobrinho AP
Oral Microbiol Immunol; 2008 Oct; 23(5):353-9. PubMed ID: 18793356
[TBL] [Abstract][Full Text] [Related]
9. Induction of cross-priming of naive CD8+ T lymphocytes by recombinant bacillus Calmette-Guerin that secretes heat shock protein 70-major membrane protein-II fusion protein.
Mukai T; Maeda Y; Tamura T; Matsuoka M; Tsukamoto Y; Makino M
J Immunol; 2009 Nov; 183(10):6561-8. PubMed ID: 19846882
[TBL] [Abstract][Full Text] [Related]
10. Role of phosphoinositide 3-kinase p110 delta in TLR4- and TLR9-mediated B cell cytokine production and differentiation.
Dil N; Marshall AJ
Mol Immunol; 2009 Jun; 46(10):1970-8. PubMed ID: 19362372
[TBL] [Abstract][Full Text] [Related]
11. Porphyromonas gingivalis fimbriae induce unique dendritic cell subsets via Toll-like receptor 2.
Kanaya S; Nemoto E; Ogawa T; Shimauchi H
J Periodontal Res; 2009 Aug; 44(4):543-9. PubMed ID: 18973528
[TBL] [Abstract][Full Text] [Related]
12. Effect of synthetic agonists of toll-like receptor 9 on canine lymphocyte proliferation and cytokine production in vitro.
Im Hof M; Williamson L; Summerfield A; Balmer V; Dutoit V; Kandimalla ER; Yu D; Zurbriggen A; Doherr MG; Peel J; Roosje PJ
Vet Immunol Immunopathol; 2008 Jul; 124(1-2):120-31. PubMed ID: 18452997
[TBL] [Abstract][Full Text] [Related]
13. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
[TBL] [Abstract][Full Text] [Related]
14. Innate-immunity cytokines induced by very small size proteoliposomes, a Neisseria-derived immunological adjuvant.
Venier C; Guthmann MD; Fernández LE; Fainboim L
Clin Exp Immunol; 2007 Feb; 147(2):379-88. PubMed ID: 17223981
[TBL] [Abstract][Full Text] [Related]
15. Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cells.
Khan S; Weterings JJ; Britten CM; de Jong AR; Graafland D; Melief CJ; van der Burg SH; van der Marel G; Overkleeft HS; Filippov DV; Ossendorp F
Mol Immunol; 2009 Mar; 46(6):1084-91. PubMed ID: 19027958
[TBL] [Abstract][Full Text] [Related]
16. Basophils can directly present or cross-present antigen to CD8 lymphocytes and alter CD8 T cell differentiation into IL-10-producing phenotypes.
Kim S; Shen T; Min B
J Immunol; 2009 Sep; 183(5):3033-9. PubMed ID: 19667092
[TBL] [Abstract][Full Text] [Related]
17. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands.
de Vos AF; Pater JM; van den Pangaart PS; de Kruif MD; van 't Veer C; van der Poll T
J Immunol; 2009 Jul; 183(1):533-42. PubMed ID: 19542464
[TBL] [Abstract][Full Text] [Related]
18. Differential activation of dendritic cells by Toll-like receptor agonists isolated from the Gram-positive vaccine vector Streptococcus gordonii.
Mayer ML; Phillips CM; Townsend RA; Halperin SA; Lee SF
Scand J Immunol; 2009 Apr; 69(4):351-6. PubMed ID: 19284500
[TBL] [Abstract][Full Text] [Related]
19. Cupressaceae pollen grains modulate dendritic cell response and exhibit IgE-inducing adjuvant activity in vivo.
Kamijo S; Takai T; Kuhara T; Tokura T; Ushio H; Ota M; Harada N; Ogawa H; Okumura K
J Immunol; 2009 Nov; 183(10):6087-94. PubMed ID: 19864594
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
Greifenberg V; Ribechini E; Rössner S; Lutz MB
Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
